Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 2.83M | $97.0M | 14.71% | +13.9K | 2026-06-30 |
| TCG Crossover Management, LLC | 1.20M | $41.0M | 6.26% | -- | 2026-06-30 |
| Aberdeen Group plc | 1.14M | $39.0M | 5.94% | -- | 2026-06-30 |
| BlackRock, Inc. | 862.6K | $29.0M | 4.48% | +2.2K | 2026-06-30 |
| First Light Asset Management, LLC | 800.7K | $27.0M | 4.16% | +153.0K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 607.8K | $20.0M | 3.16% | -- | 2026-06-30 |
| 5AM Venture Management, LLC | 606.7K | $20.0M | 3.15% | -- | 2026-06-30 |
| BRAIDWELL LP | 596.9K | $20.0M | 3.10% | -250.3K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 488.8K | $16.0M | 2.54% | +15.3K | 2026-06-30 |
| Vestal Point Capital, LP | 425.0K | $14.0M | 2.21% | +97.0K | 2026-06-30 |
